NCT06627855 Effectiveness of the Fascial Distortion Model in Temporomandibular Disorders: A Randomized Sham-controlled Trial
| NCT ID | NCT06627855 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karabuk University |
| Condition | Temporomandibular Disorders (TMD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-10-03 |
| Primary Completion | 2024-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-10-03 with a primary completion date of 2024-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study was to investigate the effectiveness of Manual Therapy Based on the Fascial Distortion Model in individuals with temporomandibular disorders compared to sham control. Individuals diagnosed with temporomandibular disorder will be randomly assigned to groups as Group 1 (Manual Therapy Based on Fascial Distortion Model) and Group 2 (Sham Control). Head posture, cervical and temporomandibular joint range of motion, cervical muscle performance, pain intensity, pressure pain thresholds, temporomandibular disorder severity, disability, dysfunction, health-related quality of life, kinesiophobia, and central sensitization will be assessed.
Eligibility Criteria
Inclusion Criteria: * Having temporomandibular joint complaints and being diagnosed with temporomandibular disorder according to the Diagnostic Criteria for Temporomandibular Disorders Axis I * Understand and be willing to answer assessment questions * A temporomandibular joint complaint for the last three months * Pain in the jaw, face or neck Exclusion Criteria: * Has a systemic disease (neurological, rheumatologic, oncologic, etc.) that may affect the temporomandibular joint, cervical spine and/or assessment * Any history of trauma that may have affected the cranio-cervico-facial region * Having undergone any surgical intervention in the cranio-cervico-facial region within the last six months * Receiving surgical treatment, medical treatment, splint therapy or physiotherapy for temporomandibular disorder in the last month * Radiotherapy in the head and neck region * Pregnancy or breastfeeding * Exercise therapy for craniocervical posture for the last month
Contact & Investigator
Harun Gençosmanoğlu, PT, MSc
PRINCIPAL INVESTIGATOR
Karabük University
Frequently Asked Questions
Who can join the NCT06627855 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 64 Years, studying Temporomandibular Disorders (TMD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06627855 currently recruiting?
Yes, NCT06627855 is actively recruiting participants. Contact the research team at harungencosmanoglu@karabuk.edu.tr for enrollment information.
Where is the NCT06627855 trial being conducted?
This trial is being conducted at Merkez, Turkey (Türkiye).
Who is sponsoring the NCT06627855 clinical trial?
NCT06627855 is sponsored by Karabuk University. The principal investigator is Harun Gençosmanoğlu, PT, MSc at Karabük University. The trial plans to enroll 30 participants.